Dual approach using proteomics and multiplexed immunofluorescence for the detection of markers predictive for immunotherapy in melanoma patients
Minimal Residual Disease (MRD) As A Predictive Biomarker/Endpoint for Novel Drug Development
Molecular profiling of RUNX1/RUNT domain in myeloid disorders
Obesity-Induced Changes in the Tumor Microenvironment Impact the Response to Chemotherapy and Overall Ovarian Cancer Metastatic Success
Pattern of PIK3CA co-alterations in endometrial cancer
Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyxTM assay
Ubiquitin ligases implicated as predictive biomarkers for poor outcome to immunotherapy in melanoma patients
Use of Receptor Occupancy Assays on cells from Peripheral Blood as a Surrogate Model of the Tumor Microenvironment